Interview with the President and CEO: Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
Raul R. Rodriguez is the President and Chief Executive Officer of Rigel Pharmaceuticals, Inc. and is on the company’s board of directors. Earlier, he was the company’s Executive Vice President and COO, after having joined Rigel in April 2000 as Vice President, Business Development. From April 1997 to March 2000, he was Senior Vice President, Business Development and Operations, for Ontogeny, Inc., a biotechnology company. From 1994 to 1997, he was the Executive Director, Business Development and Market Planning, for Scios, Inc., a pharmaceutical company. From 1989 to 1994, Mr. Rodriguez held various positions at G.D. Searle & Company, a pharmaceutical company. He received a bachelor’s degree from Harvard University, a master's degree in public health from the University of Illinois and an MBA from the Stanford Graduate School of Business. Profile
Word count: 2,746
TWST: Could you tell me about the firm?
Mr. Rodriguez: Absolutely. Rigel is a California-based biotech company, and we have been working on